|
2005 Conference Publication Not Perforin or Fas-L, is Required for Killing Keratinocytes In Vitro and In VivodeKluyver, R. L., Morritz, L., Frazer, I. H. and Lambert, P. F. (2005). Not Perforin or Fas-L, is Required for Killing Keratinocytes In Vitro and In Vivo. 2nd Annual Scientific Meeting of the Australasian Society for Dermatology Research, Perth, Australia, May 2005. Oxford, England: Blackwell Publishing. doi: 10.1111/j.0022-202X.2005.23947.x |
|
2005 Journal Article Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-B-mediated signalling, moderated by TGF-betaYan, Mengyong, Peng, Judy, Jabbar, Ibtissam A., Liu, Xiaosong, Filguueira, Luis, Frazer, Ian H. and Thomas, Ranjeny (2005). Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-B-mediated signalling, moderated by TGF-beta. Immunology and Cell Biology, 83 (1), 83-91. doi: 10.1111/j.1440-1711.2004.01291.x |
|
2005 Journal Article Interferon-gamma, but not perforin or FasL, is required for killing keratinocytes in vitro and in vivodeKluyver, R. L., Moritz, L. and Frazer, I. H. (2005). Interferon-gamma, but not perforin or FasL, is required for killing keratinocytes in vitro and in vivo. Faseb Journal, 19 (5), A1438-A1438. |
|
2005 Other Outputs Screening to prevent cervical cancer: Guidelines for the management of asymptomatic women with screen detected abnormalitiesNHMRC Guidelines Review Group, Connelly, Luke B. and Frazer, Ian (2005). Screening to prevent cervical cancer: Guidelines for the management of asymptomatic women with screen detected abnormalities. Canberra, Australia: Commonwealth of Australia. |
|
2005 Book Chapter Development of a Vaccine Against Human Papillomavirus (HPVEdwards, S. J., Basser, R. L. and Frazer, I. H. (2005). Development of a Vaccine Against Human Papillomavirus (HPV. Vaccines: Frontiers in Design and Development. (pp. 210-230) edited by Philippe Moingeon Stallergenes. United Kingdom: Horizon Bioscience. |
|
2004 Journal Article Functional memory CD8+ T cells can be generated in vivo without evident T helpAndrews, Melanie R., Peters, Tania, Khammanivong, Vithagna, Leggatt, Graham R., Frazer, Ian H. and Fernando, Germain J. P. (2004). Functional memory CD8+ T cells can be generated in vivo without evident T help. Vaccine, 23 (6), 739-742. doi: 10.1016/j.vaccine.2004.07.027 |
|
2004 Journal Article Human growth hormone (hGH) presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejectionZhong, J., Matsumoto, K., De Kluyver, R., Fernando, G. J. P., Leggatt, G. R. and Frazer, I. H. (2004). Human growth hormone (hGH) presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection. Journal of Investigative Dermatology, 123 (6), A113-A113. |
|
2004 Journal Article Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX (TM) adjuvant in women with cervical intraepithelial neoplasiaFrazer, Ian H., Quinn, Michael, Nicklin, Jim L., Tan, Jeffrey, Perrin, Lew C., Ng, Peng, O'Connor, Vivienne M., White, Olivia, Wendt, Ngaire, Martin, Juliet, Crowley, Jayne M., Edwards, Stirling J., McKenzie, Andrew W., Mitchell, Susan V., Maher, Darryl W., Pearse, Martin J. and Basser, Russell L. (2004). Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX (TM) adjuvant in women with cervical intraepithelial neoplasia. Vaccine, 23 (2), 172-181. doi: 10.1016/j.vaccine.2004.05.013 |
|
2004 Journal Article Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturationStewart, Trina J., Fernando, Germain J. P., Frazer, Ian H. and Leggatt, Graham R. (2004). Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation. Immunology and Cell Biology, 82 (5), 455-461. doi: 10.1111/j.0818-9641.2004.01273.x |
|
2004 Journal Article Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytesLeggatt, Graham R., Narayan, Sharmal, Fernando, Germain J. P. and Frazer, Ian H. (2004). Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes. Journal of Leukocyte Biology, 76 (4), 787-795. doi: 10.1189/jlb.0104026 |
|
2004 Journal Article Major quantitative trait locus for eosinophil count is located on chromosome 2qEvans, DM, Zhu, G, Duffy, DL, Montgomery, GW, Frazer, IH and Martin, NG (2004). Major quantitative trait locus for eosinophil count is located on chromosome 2q. Journal of Allergy And Clinical Immunology, 114 (4), 826-830. doi: 10.1016/j.jaci.2004.05.060 |
|
2004 Journal Article ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccinesStewart, Trina J., Drane, Debbie, Malliaros, Jim, Elmer, Heidi, Malcolm, Karen M., Cox, John C., Edwards, Stirling J., Frazer, Ian H. and Fernando, Germain J. P. (2004). ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccines. Vaccine, 22 (27-28), 3738-3743. doi: 10.1016/j.vaccine.2004.03.026 |
|
2004 Journal Article Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cellsYan, Mengyong, Peng, Judy, Abdul Jabbar, Ibtissam A., Liu, Xiaosong, Filgueira, Luis, Frazer, Ian H. and Thomas, Ranjeny (2004). Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology, 324 (2), 297-310. doi: 10.1016/j.virol.2004.03.045 |
|
2004 Journal Article Erratum: Cervical cancer control, priorities and new directions (International Journal of Cancer (2003) 108 (329-333))Monsonego, J., Bosch, F. X., Coursaget, P., Cox, J. T., Franco, E., Frazer, I., Sankaranarayanan, R., Schiller, J., Singer, A., Wright Jr., Thomas C., Kinney, W., Meijer, Chris J.L.M., Linder, J. and McGoogan, Euphemia (2004). Erratum: Cervical cancer control, priorities and new directions (International Journal of Cancer (2003) 108 (329-333)). International Journal of Cancer, 108 (6) |
|
2004 Journal Article B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gammaJuffs, Helen, Fowler, Nina, Saal, Russell, Grimmett, Karen, Beasley, Shannon, O'Sullivan, Brendan, Frazer, Ian H., Gill, Devinder and Thomas, Ranjeny (2004). B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma. Pathology, 36 (1), 69-76. doi: 10.1080/00313020310001644499 |
|
2004 Journal Article Cervical Cancer Control, Priorities and New DirectionsMonsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, Sankaranarayanan, R, Schiller, J, Singer, A, Wright, T, Kinney, W, Meijer, C and Linder, J (2004). Cervical Cancer Control, Priorities and New Directions. International Journal of Cancer, 108 (3), 329-333. doi: 10.1002/ijc.11530 |
|
2004 Journal Article A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11Evans, D. M., Zhu, G., Duffy, D. L., Frazer, I. H., Montgomery, G. W. and Martin, N. G. (2004). A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11. Genes and Immunity, 5 (7), 548-552. doi: 10.1038/sj.gene.6364126 |
|
2004 Journal Article Mutations in TAP genes are common in cervical cancinomasFowler, NL and Frazer, IH (2004). Mutations in TAP genes are common in cervical cancinomas. Gynecologic Oncology, 92 (3), 914-921. doi: 10.1016/j.ygyno.2003.11.037 |
|
2004 Book Chapter Vaccines Against Human Papillomavirus InfectionBoslego, J., Liu, X. and Frazer, I. H. (2004). Vaccines Against Human Papillomavirus Infection. New Generation Vaccines. (pp. 977-986) edited by Myron M. Levine, James B. Kaper, Rino Rappuoli, Margaret A. Liu and Michael F. Good. New York: Marcel Dekker, Inc.. |
|
2004 Journal Article Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejectionZhong, Jie, Matsumoto, Koji, De Kluyver, Rachel, Fernando, Germain J. P., Leggatt, Graham R. and Frazer, Ian H. (2004). Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection. Immunology and Cell Biology, 82 (6), 577-586. doi: 10.1111/j.1440-1711.2004.01292.x |
